by Eric Celidonio | Nov 6, 2024 | Issue 4: Q4 2024
Will the Trump Administration Create More Headwinds for the Biopharma Sector? What’s in store? Donald Trump’s return to the presidency has the potential to bring significant changes to U.S. health care policy. His administration promised to empower figures like...
by Eric Celidonio | Aug 5, 2024 | Issue 3: Q3 2024
Glassdoor’s Decline: Why Going Back to Basics is (and has always been) Key for Genuine Company Insights Glassdoor was once the go-to for semi-authentic company reviews, but since its acquisition by Recruit Holdings Co., Ltd., it seems the site is being...
by Eric Celidonio | Apr 20, 2024 | Issue 2: Q2 2024
Dive into the latest biotech Buzz! Discover groundbreaking advancements, regulatory updates, and insights shaping the biotech landscape. The Defeat of Non Compete? The Federal Trade Commission (FTC) has implemented a rule banning most noncompete agreements, aiming to...
by Eric Celidonio | Feb 27, 2024 | Issue 1: Q1 2024
Dive into the latest biotech Buzz! Discover groundbreaking advancements, regulatory updates, and insights shaping the biotech landscape. Links to some of the most interesting news from across the internet, curated by our team: Renewed hope as biotech heads into 2024...